STRS Ohio’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

STRS Ohio’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,751	Closed	-$596K	–	2066
2023 Q2	$596K	Sell	2,751 -2,849	-51%	-$610K	﹤0.01%	1179
2023 Q1	$1.02M	Sell	5,600 -2,000	-26%	-$383K	﹤0.01%	933
2022 Q4	$1.49M	Sell	7,600 -1,500	-16%	-$322K	0.01%	766
2022 Q3	$2.05M	Buy	9,100 +4,500	+98%	+$911K	0.01%	583
2022 Q2	$581K	Buy	4,600 +300	+7%	+$34.5K	﹤0.01%	1281
2022 Q1	$545K	Hold	4,300	–	–	﹤0.01%	1409
2021 Q4	$563K	Hold	4,300	–	–	﹤0.01%	1440
2021 Q3	$526K	Hold	4,300	–	–	﹤0.01%	1489
2021 Q2	$490K	Buy	4,300 +400	+10%	+$46.8K	﹤0.01%	1566
2021 Q1	$468K	Sell	3,900 -100	-3%	-$11.3K	﹤0.01%	1597
2020 Q4	$406K	Hold	4,000	–	–	﹤0.01%	1567
2020 Q3	$309K	Hold	4,000	–	–	﹤0.01%	1556
2020 Q2	$445K	Buy	4,000 +1,300	+48%	+$113K	﹤0.01%	1385
2020 Q1	$194K	Buy	2,700 +1,500	+125%	+$128K	﹤0.01%	1556
2019 Q4	$90K	Hold	1,200	–	–	﹤0.01%	1798
2019 Q3	$19K	Buy	+1,200	New	+$23.3K	﹤0.01%	1982

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

STRS Ohio's KRTX Position: Q3 2023 in Review

STRS Ohio sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 2,751 shares — an estimated $596K sold.

STRS Ohio first reported a position in KRTX in Q3 2019 and held it in 16 quarters. The position peaked at $2.05M in Q3 2022. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

STRS Ohio reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
STRS Ohio sold 2,751 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $596K.
STRS Ohio first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
STRS Ohio's Karuna Therapeutics, Inc. Common Stock position peaked at $2.05M in Q3 2022.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on STRS Ohio's 13F filing for Q3 2023, filed 26 Oct 2023.